Clinical Trial Update: A Trial to Determine the Long-term Durability of Virologic Suppression in Kaletra Recipients With Imperfect Adherence [Phase 4]

View source ↗

Summary

A completed Phase 4 trial evaluating the durability of virologic suppression in HIV patients treated with Kaletra (lopinavir/ritonavir) who show imperfect adher…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: Montefiore Medical Center | Conditions: HIV Infection | Phase 4 | Status: COMPLETED